Relevant bibliographies by topics / Human t-cell leukemia viru / Books

Books on the topic 'Human t-cell leukemia viru'

To see the other types of publications on this topic, follow the link: Human t-cell leukemia viru.
Author: Grafiati
Published: 11 March 2023

Create a spot-on reference in APA, MLA, Chicago, Harvard, and other styles

Select a source type:

Consult the top 18 books for your research on the topic 'Human t-cell leukemia viru.'

Next to every source in the list of references, there is an 'Add to bibliography' button. Press on it, and we will generate automatically the bibliographic reference to the chosen work in the citation style you need: APA, MLA, Harvard, Chicago, Vancouver, etc.

You can also download the full text of the academic publication as pdf and read online its abstract whenever available in the metadata.

Browse books on a wide variety of disciplines and organise your bibliography correctly.

1

Vogt, Peter K., ed. Human T-Cell Leukemia Virus. Berlin, Heidelberg: Springer Berlin Heidelberg, 1985. http://dx.doi.org/10.1007/978-3-642-70113-9.

Full text
APA, Harvard, Vancouver, ISO, and other styles
2

1932-, Vogt P. K., ed. Human T-cell leukemia virus. Berlin: Springer, 1985.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
3

Essex, Myron. Selected abstracts on viral etiology of human cancer.: Human T-cell leukemia viruses. Bethesda, MD: U.S. Dept. of Health and Human Services, Public Health Service, National Institutes of Health, 1986.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
4

Kenton, Charlotte. Human T-cell leukemia/lymphoma virus (HTLV), January 1982 through September 1984, 234 citations. [Bethesda, Md.]: U.S. Dept. of Health and Human Services, Public Health Service, National Institutes of Health, 1985.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
5

Symposium, Takamatsu no Miya Hi Gan Kenkyū Kikin International. Retroviruses in human lymphoma/leukemia: Proceedings of the 15th International Symposium of the Princess Takamatsu Cancer Research Fund, Tokyo, 1984. Tokyo: Japan Scientific Societies Press, 1985.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
6

C, Román Gustavo, Vernant Jean-Claude, Osame Mitsuhiro, Texas Tech University. Dept. of Neurology., Meynard Hospital. Dept. of Neurology., and International Symposium on HTLV-I and the Nervous System (1968 : Meynard Hospital., eds. HTLV-I and the nervous system: Proceedings of an international meeting organized by the Departments of Neurology of Texas Tech University and La Meynard Hospital, held in Fort-de-France, Martinique, French Antilles, April 15-16, 1988. New York: Liss, 1989.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
7

Jean, Otter, and American Association of Blood Banks., eds. Current status of HTLV-III testing. Arlington, Va: American Association of Blood Banks, 1986.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
8

E, Menitove Jay, Kolins Jerry, American Association of Blood Banks. Committee on Technical/Scientific Workshops., and AIDS Technical Workshop (1986 : San Francisco, Calif.), eds. AIDS. Arlington, Va: American Association of Blood Banks, 1986.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
9

Vogt, Peter K. Human T-Cell Leukemia Virus. Brand: Springer, 2011.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
10

Vogt, P. K. Human T-Cell Leukemia Virus. Springer London, Limited, 2012.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
11

Human T-Cell Leukemia Virus. Springer, 2011.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
12

Human T-Cell Leukemia Virus. Springer Verlag, 1985.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
13

Moriuchi, Hiroyuki. Human T-cell Lymphotropic Virus. Oxford University Press, 2018. http://dx.doi.org/10.1093/med/9780190604813.003.0010.

Full text
Abstract:
Human T-cell lymphotropic virus type 1 (HTLV-1), a human retrovirus that infects an estimated 10–20 million people worldwide, has endemic foci in Japan, West and Central Africa, the Caribbean, Central and South America, and Melanesia. Also, it is the etiological agent of a lymphoproliferative malignancy, adult T-cell leukemia/lymphoma (ATLL), as well as chronic inflammatory diseases such as HTLV-1-associated myelopathy/tropical spastic paraparesis (HAM/TSP). HTLV-1 can be transmitted vertically, sexually, or by blood-borne transmission. ATLL occurs in approximately 5% of carriers who are infected during early childhood, and primary prevention is the only strategy likely to reduce this fatal disease. Children born to carrier mothers acquire the virus predominantly from breastfeeding. In endemic areas, mother-to-child transmission (MTCT) can be significantly reduced by screening pregnant women for the HTLV-1 antibody, followed by replacing breastfeeding with exclusive formula feeding. Indications for serological screening and recommendations for prevention of perinatal transmission are reviewed in this chapter.
APA, Harvard, Vancouver, ISO, and other styles
14

Sugamura, Kazuo, ed. Two Decades of Adult T Cell Leukemia and HTLV-1 Research (Gann Monographs on Cancer Research). Karger, 2003.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
15

Modeling the risk of adult T-cell leukemia/lymphoma in persons infected with human T-lymphotropic virus Type I. [Bethesda, Md.?]: National Cancer Institute, Office of Cancer Communications, 1988.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
16

Roman, Eve, Alexandra Smith, and Lorelei Mucci. Leukemias. Oxford University Press, 2018. http://dx.doi.org/10.1093/oso/9780190676827.003.0028.

Full text
Abstract:
Leukemias are a diverse group of acute and chronic haematological malignancies, that account for 2% to 3% of cancers globally. Recent advances in molecular biology and therapy have transformed the landscape for several leukemia subtypes changing some, but by no means all, from rapidly fatal diseases to treatable conditions with a good prognosis. In general, however, this progress has not been matched by new aetiological insights. Albeit accounting for a relatively small proportion, genetic predisposition syndromes such as neurofibromatosis, Li-Fraumeni and Trisomy 21, have the biggest impact in children and young adults. At older ages, established chemical, physical and biological risk factors, which explain only a small proportion of the total disease burden, include chemotherapy for a preceding cancer, ionizing radiation, and the viral infections human T-cell lymphotropic virus type 1 (HTLV-1) which causes the rare adult T-cell leukemia/lymphoma (ATLL) and the human immunodeficiency virus (HIV) which is associated with an increased risk of acute lymphoid leukaemias. Workplace exposures to potential carcinogens such as benzene, butadiene, and styrene have also been linked to increased risk of leukemia.
APA, Harvard, Vancouver, ISO, and other styles
17

Franceschi, Silvia, Hashem B. El-Serag, David Forman, Robert Newton, and Martyn Plummer. Infectious Agents. Oxford University Press, 2017. http://dx.doi.org/10.1093/oso/9780190238667.003.0024.

Full text
Abstract:
Eleven infectious agents (seven viruses, three parasites, and one bacterium) have been classified by the International Agency for Research on Cancer as carcinogenic to humans for one or more cancer sites: hepatitis B virus; hepatitis C virus; thirteen types of human papillomavirus (HPV); human immunodeficiency virus type 1 (HIV-1); human T-cell leukemia virus type 1; Epstein-Barr virus; Kaposi sarcoma herpesvirus; Helicobacter pylori; Opisthorchis viverrini; Clonorchis sinensis; and Schistosoma haematobium. Other infectious agents, such as Merkel cell polyomavirus, Plasmodium falciparum, and cutaneous HPVs, have been classified as “probably carcinogenic” or “possibly carcinogenic.” Accurate biomarkers of chronic infection have been essential for estimating risk and ascribing a causal role to infectious agents in cancer. Of the 14 million cases of cancer estimated to have occurred worldwide in 2012, 2.2 million were caused by infectious agents. Vaccination and screen-and-treat programs have the potential for greatly reducing the burden of cancer caused by infections.
APA, Harvard, Vancouver, ISO, and other styles
18

Human T-cell Leukemia Vir (Current Topics in Microbiology and Immunology). Springer, 1985.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
You might also be interested in the bibliographies on the topic 'Human t-cell leukemia viru' for other source types:
Journal articles Dissertations / Theses
We offer discounts on all premium plans for authors whose works are included in thematic literature selections. Contact us to get a unique promo code!

To the bibliography